These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29235200)

  • 1. Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis.
    Serio A; Patani R
    Stem Cells; 2018 Mar; 36(3):293-303. PubMed ID: 29235200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models.
    Nizzardo M; Bucchia M; Ramirez A; Trombetta E; Bresolin N; Comi GP; Corti S
    Hum Mol Genet; 2016 Aug; 25(15):3152-3163. PubMed ID: 27270413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).
    Haidet-Phillips AM; Maragakis NJ
    Brain Res; 2015 Dec; 1628(Pt B):343-350. PubMed ID: 26187754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Human Pluripotent Stem Cells in Amyotrophic Lateral Sclerosis: From Biological Mechanism to Practical Implications.
    Ceccarelli L; Verriello L; Pauletto G; Valente M; Spadea L; Salati C; Zeppieri M; Ius T
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):114. PubMed ID: 38538275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.
    Van Harten ACM; Phatnani H; Przedborski S
    Trends Neurosci; 2021 Aug; 44(8):658-668. PubMed ID: 34006386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future.
    Lunn JS; Sakowski SA; Feldman EL
    Stem Cells; 2014 May; 32(5):1099-109. PubMed ID: 24448926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells from ALS patients for disease modeling.
    Richard JP; Maragakis NJ
    Brain Res; 2015 May; 1607():15-25. PubMed ID: 25223906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis.
    Abati E; Bresolin N; Comi G; Corti S
    Mol Neurobiol; 2019 Oct; 56(10):6703-6715. PubMed ID: 30911936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
    Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
    Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis.
    Ziff OJ; Patani R
    Aging Cell; 2019 Feb; 18(1):e12862. PubMed ID: 30565851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients.
    Liu ML; Zang T; Zhang CL
    Cell Rep; 2016 Jan; 14(1):115-128. PubMed ID: 26725112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug screening for ALS using patient-specific induced pluripotent stem cells.
    Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
    Sci Transl Med; 2012 Aug; 4(145):145ra104. PubMed ID: 22855461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells in modeling and cell-based therapy of amyotrophic lateral sclerosis.
    Csobonyeiova M; Polak S; Nicodemou A; Danisovic L
    J Physiol Pharmacol; 2017 Oct; 68(5):649-657. PubMed ID: 29375039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.